Forschung
SARS-CoV-2 Research
The research groups at CiiM are collaborating to address various current issues in SARS-CoV-2 research.
The very diverse clinical histories suggest that a mixture of epidemiological, genetic, and immunological factors, as well as metabolic processes, are involved in disease development. In various projects involving the CiiM groups, research is being conducted to understand individual risk and its predictability. For this, a comprehensive characterization of patients and disease progression is essential.
© Copyright
Project
COVID-19 patient cohort
CiiM is involved in the establishment of a COVID-19 patient cohort
